Indian medical devices more cost-effective: Union Minister – ETHealthWorld

Share Article

Dear user,

ET HealthWorld privacy and cookie policy has been updated to align with the new data regulations in European Union. Please review and accept these changes below to continue using the website.

You can see our privacy policy & our cookie policy. We use cookies to ensure the best experience for you on our website.

If you choose to ignore this message, we’ll assume that you are happy to receive all cookies on ET HealthWorld.
Cervical Cancer Elimination Day of Action: India will soon introduce HPV vaccination, says WHO
Over 1 billion youngsters at hearing loss risk due to headphones, loud music: Study



25 February, 2022
25 February, 2022
25 November, 2022
1 Octuber, 2021

Rebooting Cancer Awareness
The unsung hero in faster holistic recovery
Technological Disruption in Indian Health & Pharma
Do you think you are up for the challenge?
Holistic Solutions For A Healthier India






Adopting-Dynamic-Technologies


The Minister of State (independent charge) for Science and Technology was addressing the faculty and students after inaugurating the combined devices block at the Sree Chitra Tirunal Institute of Medical Sciences and Technology (SCTIMST) here. Technologies like the artificial heart valve, hydrocephalus shunt, oxygenator and drug-eluting intra-uterine device developed by the SCTIMST are being manufactured in countries like the USA, Japan, Brazil, and China, he said.
Recommended by ColombiaColumbia
125000+ Industry Leaders read it everyday
“The company learnt that P Sarath Chandra Reddy, whole-time director/ promoter group of the company, has been arrested by the Enforcement Directorate. The company is in the process of ascertaining further details and will do further disclosures as appropriate,” Aurobindo Pharma said in a stock exchange filing on Thursday.
“The company learnt that P Sarath Chandra Reddy, whole-time director/ promoter group of the company, has been arrested by the Enforcement Directorate. The company is in the process of ascertaining further details and will do further disclosures as appropriate,” Aurobindo Pharma said in a stock exchange filing on Thursday.
We have various options to advertise with us including Events, Advertorials, Banners, Mailers, Webinars etc.
Please contact us to know more details.
Get ETHealthworld‘s top stories every morning in your email inbox.
125000+ Industry Leaders read it everyday
Follow @ETHealthworld for the latest news, insider access to events and more.

source

You might also like

Surviving 2nd wave of corona
COVID-19

Surviving The 2nd Wave of Corona

‘This too shall pass away’ this famous Persian adage seems to be defeating us again and again in the case of COVID-19. Despite every effort

@voguewellness